Foghorn Therapeutics
FHTX
88 hedge funds and large institutions have $200M invested in Foghorn Therapeutics in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
9% more funds holding
Funds holding: 81 → 88 (+7)
4% more capital invested
Capital invested by funds: $193M → $200M (+$7.69M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.14% less ownership
Funds ownership: 73.49% → 72.35% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$854K |
| 2 |
Millennium Management
New York
|
+$849K |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$576K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$505K |
| 5 |
State Street
Boston,
Massachusetts
|
+$496K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.58M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$920K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$705K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$556K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$528K |
FHTX Hedge Fund Activity: Q3 2025 in Review
88 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q3 2025, worth a combined $200M — up 4% from $193M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new FHTX positions and 9 closed out — a net gain of 7 holders — while 27 added to existing stakes and 23 trimmed.
The largest buyer was Readystate Asset Management, opening a new position worth an estimated $854K. The largest seller was Point72 Asset Management, cutting an estimated $1.58M.
- 88 institutional investors held Foghorn Therapeutics (FHTX) as of Q3 2025, up from 81 in Q2 2025.
- Funds reported $200M of Foghorn Therapeutics stock for Q3 2025, up 4% quarter-over-quarter.
- 16 funds opened new Foghorn Therapeutics positions in Q3 2025 and 9 closed out, a net change of +7 holders.
- The largest Foghorn Therapeutics buyer in Q3 2025 was Readystate Asset Management, an estimated $854K added.
- The largest Foghorn Therapeutics seller in Q3 2025 was Point72 Asset Management, an estimated $1.58M sold.
Based on aggregated 13F filings for Q3 2025.